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A controlled  study  to assess  the  acaricidal  efﬁcacy  of afoxolaner  in  dogs  after  a  single  oral
administration  was  conducted  against  Haemaphysalis  longicornis  ticks.  The  study  was  char-
acterized by  a negative  controlled  randomized  block  design  and  included  sixteen  beagle
dogs  of both  sexes.  Starting  two  days  before  treatment,  each  dog  was  infested  weekly
with 50  ticks  over  4 weeks.  The  number  of  live  ticks  was  determined  48 h  after  treatmentfﬁcacy and  then  48 h  after  each  infestation.  The  mean  dose  of  afoxolaner  received  by dogs  was
3.0 mg/kg  (range:  2.5–3.1  mg/kg).  Afoxolaner  rapidly  eliminated  pre-existing  tick  infesta-
tions (100%  ticks  killed  within  48 h of  treatment)  and  controlled  weekly  re-infestations
(91.9%  prophylactic  efﬁcacy  at  Day  30).
©  2014  The  Authors.  Published  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
Y-NC-NB
. Introduction
Haemaphysalis longicornis is common tick species in Asia
nd Paciﬁc region, including Japan, China, Korea, Australia
nd New Zealand (Inokuma, 2013; Shimada et al., 2003;
enquisf and Charleston, 2001). This species is the major
ector of Babesia gibsoni to dogs in Asia (Chomel, 2011;
nokuma, 2013). Canine babesiosis is an important tick-
orne disease, and the prevention of Babesia transmission
s particularly critical given the challenges of appropriate
reatment strategies against babesiosis (Beugnet and Franc,
012; Otranto and Wall, 2008; Otranto et al., 2009a,b;
aboada and Lobetti, 2006). H. longicornis is also a puta-
ive vector of Hepatozoon canis and Rickettsia japonica
Inokuma, 2013).
∗ Corresponding author at: Merial Japan Limited, Tokyo Opera City
ower, 3-20-2, Nishi Shinjuku, Shinjuku-ku, Tokyo 163-1488, Japan.
E-mail address: yumi.kondo@merial.com (Y. Kondo).
http://dx.doi.org/10.1016/j.vetpar.2014.02.019
304-4017/© 2014 The Authors. Published by Elsevier B.V. This is an open acce
icenses/by-nc-nd/3.0/).D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
The present study describes the result of a laboratory
study that assessed the efﬁcacy of afoxolaner, adminis-
tered orally in a chewable formulation (Nexgard®, Merial),
against H. longicornis in dogs.
2. Materials and methods
Sixteen beagle dogs of both sexes were included in the
study, which was  designed as a negative controlled ran-
domized block study. All dogs were approximately 10–11
months of age and weighed from 7.2 to 9.0 kg at inclusion.
All dogs were healthy and had not been treated with
any ectoparasiticides in the 3 months prior to inclusion in
the study nor infested by ticks. The health of all dogs was
monitored at least once daily and once per hour during the
ﬁrst four hours post treatment. All dogs had free access to
water and were fed a commercial diet. The study design
was approved by the Merial Institutional Animal Care and
Use Committee (USDA, 2008).
In the study, two  groups of eight dogs were formed
randomly, using blocks of two  dogs based on decreasing
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Table 1
Geometric tick counts and percent efﬁcacy of afoxolaner oral treatment
against Haemaphysalis longicornis after challenges with 50 female ticks.
Study daya Geometric mean tick counts
(min–max)
% Efﬁcacy
Control Treated
2b 23.7 (4–38) 0.0 (0–0) 100
9 16.7 (8–29) 0.0 (0–0) 100
16  15.8 (6–37) 0.4 (0–2) 97.7
23  13.9 (6–25) 0.6 (0–6) 95.5
30 20.2 (15–33) 1.6 (0–7) 91.9
a Live H. longicornis were counted 48 h after treatment or infestation.230 Y. Kondo et al. / Veterinary
pre-treatment tick counts. Dogs in Group 1 were untreated
controls. Dogs in Group 2 were treated orally on Day 0 with
the appropriate chewable tablets containing afoxolaner.
Four sizes of chews were available: 0.5 g, 1.25 g, 3 g and
6 g, containing respectively 11.3 mg,  28.3 mg,  68 mg  and
136 mg  of afoxolaner. Doses were administered as closely
as possible to the minimum effective dose (2.5 mg/kg). In
this study, all dogs received 2 chewable tablets of 0.5 g,
and the mean dose received by dogs was 3.0 mg/kg of afox-
olaner (range: 2.5–3.1 mg/kg).
On Days-2, 7, 14, 21, and 28, all dogs were infested with
50 unfed female H. longicornis.  The study utilized ticks from
laboratory-maintained populations that had been estab-
lished from ticks collected in ﬁeld locations in Japan. Ticks
were counted 48 h after treatment (Day 2) or after infesta-
tions on Days 9, 16, 23, and 30. Counting of ticks on the dogs
was performed by parting and feeling through dog’s hair
with ﬁnger tips. All personnel conducting tick counts and
health observations were blinded to treatment groups. The
study design was in accordance with the World Association
for the Advancement of Veterinary Parasitology (WAAVP)
guidelines for evaluating the efﬁcacy of parasiticides for the
treatment, prevention and control of ﬂea and tick infesta-
tion on dogs and cats (Marchiondo et al., 2013), and was
conducted in compliance with VICH GL9 “Good Clinical
Practice” (EMEA, 2000).
For each tick count, the total count of live ticks was
transformed to the natural logarithm (count +1) to cal-
culate the geometric mean for each treatment group. The
percent reduction of the live tick counts from treated dogs
compared to those from untreated dogs (=percentage efﬁ-
cacy) was calculated using the formula [(C − T)/C] × 100,
where C is the geometric mean for the control group and T is
the geometric mean for the treated group at the same time
point. The log-counts of the live ticks of the treated group
were compared to the log-counts of the untreated con-
trol group using an F-test adjusted for the allocation blocks
used to randomize the animals to the treatment groups at
each time point separately. All testing was two-sided at the
signiﬁcance level p = 0.05.
3. Results
At each time point, the geometric mean counts of the
live ticks in the control group ranged between 13.9 and
23.7 (Table 1). This level of infestation in the control group
was adequate for determining efﬁcacy against ticks. The
WAAVP guideline recommends that at least 20% of the ticks
should be retained from the infestation, meaning an aver-
age of 10 ticks per dog out of the 50 used to infest each dogs
(Marchiondo et al., 2013).
The curative efﬁcacy of afoxolaner against pre-existing
tick infestation was 100% at 48 h after treatment (Table 1).
The tick efﬁcacy of afoxolaner on weekly re-infestations
starting on Day 7 after treatment provided 100% acaricidal
efﬁcacy at Day 9 and over 91.9% efﬁcacy at all subsequent
time points up to Day 30 (Table 1). The tick counts were
signiﬁcantly different in treated and control dogs at all time
points (p < 0.05).
One dog in the untreated control group was removed
from the study on Day 21 due to mild seizures observed onDay  0 is the day of treatment.
b Dogs were infested before treatment on Day-2.
Day 17 and Day 21. All data on the dog captured prior to
removal were included in the analysis. No adverse reaction
to the treatment was  observed during this study.
4. Discussion
The attachment rate of the ticks was lower than what is
usually observed for other tick species infesting dogs such
as Rhipicephalus sanguineus (Kunkle et al., 2014). This is
known to occur for H. longicornis,  which is more adapted
to wild ruminants than dogs in the adult stage (Inokuma,
2013; unpublished data). In this experiment, 4 ticks at Day
2 and 6 ticks at Day 16 were recovered from one control
dog. It is below the 20% of attachment rate proposed by
Marchiondo et al. (2013). Nevertheless the geometric mean
count values ranged from 13.9 to 23.7 which were above
the 20% attachment rate. The geometric mean counts were
used to calculate the percent efﬁcacy, which is therefore
valid based on the guidelines (Marchiondo et al., 2013).
A single oral treatment with the chewable formulation
of afoxolaner achieved 100% curative efﬁcacy for treating
preexistent infestation of H. longicornis. It also controlled
re-infestation by eliminating >90% of the ticks within the
ﬁrst 48 h after infestation for 4 weeks after treatment. The
Day 30 efﬁcacy of afoxolaner seems lower than what has
been observed for other tick species (Kunkle et al., 2014;
Mitchell et al., 2014). This may  be related to a lower attach-
ment rate in the control dogs, but also the variability of each
experiment.
There are some reports on the efﬁcacy of current
veterinary topical products against H. longicornis,  e.g. imi-
dacloprid/permethrin, ﬁpronil/(S)-methoprene (Hagimori
et al., 2005). However, unlike these topical combinations,
ticks are exposed to afoxolaner while feeding on the
host’s blood. Afoxolaner is absorbed rapidly by the intesti-
nal mucosa, and its plasma concentration peaks within
2–4 h after administration (Letendre et al., 2014), which
ultimately results in rapid uptake of the active ingredi-
ent by the ticks and a tick efﬁcacy assessed at 48 h is
similar to that of imidacloprid/permethrin or ﬁpronil/(S)-
methoprene combinations (Hagimori et al., 2005).
The systemic distribution offers advantages compared
to topical formulations. There is no period after treatment-
administration during which the application site should be
avoided by the owners and wetting of the haircoat or any
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ther topical treatment does not interfere with the product
fﬁcacy.
Another product for oral administration containing
pinosad includes a registered claim for H. longicornis tick
urative treatment in Japan (Comfortis1); however, this
roduct is not registered for use against ticks elsewhere
Beugnet and Franc, 2012; Snyder et al., 2009). Snyder et al.
2009) reported a limited, short-lasting efﬁcacy of 50 mg/kg
pinosad against new tick infestations on dogs with 67.8%
fﬁcacy at Day 9, 49.1% at Day 14, dropping to 5% at Day
0, against Rhipicephalus sanguineus by counting ticks 48 h
fter infestations. In this study, afoxolaner provided both
urative and prophylactic efﬁcacy for up to 30 days against
. longicornis.
Nexgard® chewable formulation containing afoxolaner
epresents the ﬁrst oral ectoparasiticide treatment provid-
ng a month-long efﬁcacy against H. longicornis, the main
apanese tick species infesting dogs.
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